MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type

    D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Explore the features of cognitive disorders and neuroimaging features of Parkinson's disease (PD) and Alzheimer's disease (AD) in the comparative aspect. Methods: Study 64…
  • 2016 International Congress

    Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia

    K. Abe, T. Hayashi, N. Akiyama, M. Yamamoto, M. Fujita (Nishinomiya, Japan)

    Objective: To test usefulness of arterial spin labeling (ASL) perfusion MRI for diagnoses of Parkinson's disease (PD) with dementia. Background: Dopamine transporter (DAT) images may…
  • 2016 International Congress

    How do we make mistakes diagnosing movement disorders?

    J. Rosales, N. Larripa, C.A. Del Carpio, S.A. Rodríguez-Quiroga, L. Assante, J. Cassen, T. Arakaki, N.S. Garretto (Caba, Argentina)

    Objective: Analyze diagnostic errors in a Movement Disorder Section (MDS) in a public hospital in Buenos Aires, Argentina. Background: Abnormal movements are a common complaint…
  • 2016 International Congress

    Correlation between Parkinson’s disease and malignant tumors

    E. Binaghi, M.M. Mascia, P. Solla, M. Meloni, R. Farris, D. Ciaccio, G. Orofino, F. Marrosu, A. Cannas (Cagliari, Italy)

    Objective: We have carried out the research among the group of Sardinian patients with PD, led by our Ambulatory of Movement Disorders, to evaluate the…
  • 2016 International Congress

    Parkinson’s disease-linked mutation in DNAJC13 causes specific trafficking defect in endosomal pathway

    S. Yoshida, T. Hasegawa, R. Oshima, J. Kobayashi, N. Sugeno, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)

    Objective: The aim of this study is to investigate the effect of mutant DNAJC13 on the vesicle transport machinery using cultured cellular model. Background: Recently,…
  • 2016 International Congress

    Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease

    M. Heldmann, J. Heeren, L. Rauch, C. Klein, T.F. Münte, M. Kasten, N. Brüggemann (Lübeck, Germany)

    Objective: Investigating brain structure and cognition in healthy individuals with positive Parkinson's disease (PD) risk markers (hyposmia, increased hyperechogenic area of the substantia nigra). Background:…
  • 2016 International Congress

    Impact of white matter hyperintensity on motor compensation in Parkinson’s disease

    J.J. Lee, Y. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Korea)

    Objective: To investigate the potential impact of white matter hyperintensity (WMH) on motor compensation in Parkinson's disease (PD). Background: WMHs, the loss of vascular integrity,…
  • 2016 International Congress

    The efficacy of quantitative 99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

    C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)

    Objective: We aim to establish the normal reference with quantitative 99mTc-Trodat-1 (TRODAT) SPECT and verify the diagnostic performance in aged Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    Targeted over-expression with AAV-mediated human α-synuclein in a rat model of Parkinson’s disease – Validation of novel fine motor functional effects

    R. Pussinen, T. Ahtoniemi, T. Huhtala, O. Kontkanen, A. Nurmi (Kuopio, Finland)

    Objective: Targeted over-expression of human α-synuclein using viral-vector mediated gene delivery into the substantia nigra of rats and non-human primates has been reported to lead…
  • 2016 International Congress

    Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder

    J. Rodrigues Brazète, J.F. Gagnon, R.B. Postuma, P.A. Bourgouin, D. Petit, J. Montplaisir (Montreal, QC, Canada)

    Objective: To investigate whether spectral analysis at baseline in rapid eye movement (REM) sleep can differentiate patients with REM sleep behavior disorder (RBD) who will…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley